Eli Lilly

• 12/26/2024

  Obesity Drug Setback Sparks Retail Rush into Novo Nordisk

• 12/24/2024

  Eli Lilly’s Unstoppable Rise: A Pharmaceutical Powerhouse

• 12/23/2024

  FDA Greenlights Revolutionary Sleep Apnea Treatment, Offering New Hope to Millions

• 12/23/2024

  Tirzepatide Shortage Ends: What It Means for Patients and Pharmacies

• 12/23/2024

  Volatility Alert: Interest Rates, Inflation, and Shutdown Fears Roil Markets

• 12/23/2024

  Stock Market Rebounds: Inflation Fears Ease and Stocks Soar

• 12/21/2024

  Novo Nordisk’s Weight Loss Hope Falters: Shares Tumble 24%

• 12/8/2024

  Market Pulse: Winners, Losers, and Surprises

• 12/8/2024

  Zepbound vs Wegovy: New Obesity Treatment Wins in Head-to-Head Trial

• 11/23/2024

  Eli Lilly and Pfizer: What’s Next for Big Pharma’s Powerhouses?